Cargando…
Prevalence and correlates of depression and anxiety among patients with HIV on-follow up at Alert Hospital, Addis Ababa, Ethiopia
BACKGROUND: Depression and anxiety disorders are common among people living with Human Immunodeficiency Virus than the non-infected individuals. The co-existence of these disorders are associated with barriers to treatment and worsening medical outcomes, including treatment resistance, increased ris...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094082/ https://www.ncbi.nlm.nih.gov/pubmed/27806711 http://dx.doi.org/10.1186/s12888-016-1037-9 |
_version_ | 1782465056425902080 |
---|---|
author | Tesfaw, Getachew Ayano, Getinet Awoke, Tadesse Assefa, Dawit Birhanu, Zelalem Miheretie, Getenet Abebe, Genet |
author_facet | Tesfaw, Getachew Ayano, Getinet Awoke, Tadesse Assefa, Dawit Birhanu, Zelalem Miheretie, Getenet Abebe, Genet |
author_sort | Tesfaw, Getachew |
collection | PubMed |
description | BACKGROUND: Depression and anxiety disorders are common among people living with Human Immunodeficiency Virus than the non-infected individuals. The co-existence of these disorders are associated with barriers to treatment and worsening medical outcomes, including treatment resistance, increased risk for suicide, greater chance for recurrence and utilization of medical resources and/or increase morbidity and mortality. Therefore, assessing depression and anxiety among HIV patients has a pivotal role for further interventions. METHODS: Institution based cross-sectional study was conducted at ALERT hospital May, 2015. Data were collected using a pretested, structured and standardized questionnaire. Systematic sampling technique was used to select the study participants. Binary logistic regression analysis was used to identify associated factors. Odds ratio with 95 % CI was computed to assess the strength of associations. RESULTS: The prevalence of co-morbid depression and anxiety among HIV patients was 24.5 % and prevalence of depression and anxiety among HIV patients was 41.2 % (172) and 32.4 % (135) respectively. Multivariate analysis showed that individual who had perceived HIV stigma (AOR = 3.60, 95 % CI (2.23, 5.80), poor social support (AOR = 2.02, 95 % CI (1.25, 3.27), HIV stage III (AOR = 2.80, 95 % CI (1.50, 5.21) and poor medication adherence (AOR = 1.61, 95 % CI (1.02, 2.55) were significantly associated with depression. Being female (AOR = 3.13, 95 % CI (1.80, 5.44), being divorced (AOR = 2.51, 95 % CI (1.26, 5.00), having co morbid TB (AOR = 2.74, 95 % CI (1.37, 5.47) and perceived HIV stigma (AOR = 4.00, 95 % CI (2.40, 6.69) were also significantly associated with anxiety. CONCLUSION: Prevalence of depression and anxiety was high. Having perceived HIV stigma, HIV Stage III, poor social support and poor medication adherence were associated with depression. Whereas being female, being divorced and having co morbid TB and perceived HIV stigma were associated with anxiety. Ministry of health should give training on how to screen anxiety and depression among HIV patients and should develop guidelines to screen and treat depression and anxiety among HIV patients. |
format | Online Article Text |
id | pubmed-5094082 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-50940822016-11-07 Prevalence and correlates of depression and anxiety among patients with HIV on-follow up at Alert Hospital, Addis Ababa, Ethiopia Tesfaw, Getachew Ayano, Getinet Awoke, Tadesse Assefa, Dawit Birhanu, Zelalem Miheretie, Getenet Abebe, Genet BMC Psychiatry Research Article BACKGROUND: Depression and anxiety disorders are common among people living with Human Immunodeficiency Virus than the non-infected individuals. The co-existence of these disorders are associated with barriers to treatment and worsening medical outcomes, including treatment resistance, increased risk for suicide, greater chance for recurrence and utilization of medical resources and/or increase morbidity and mortality. Therefore, assessing depression and anxiety among HIV patients has a pivotal role for further interventions. METHODS: Institution based cross-sectional study was conducted at ALERT hospital May, 2015. Data were collected using a pretested, structured and standardized questionnaire. Systematic sampling technique was used to select the study participants. Binary logistic regression analysis was used to identify associated factors. Odds ratio with 95 % CI was computed to assess the strength of associations. RESULTS: The prevalence of co-morbid depression and anxiety among HIV patients was 24.5 % and prevalence of depression and anxiety among HIV patients was 41.2 % (172) and 32.4 % (135) respectively. Multivariate analysis showed that individual who had perceived HIV stigma (AOR = 3.60, 95 % CI (2.23, 5.80), poor social support (AOR = 2.02, 95 % CI (1.25, 3.27), HIV stage III (AOR = 2.80, 95 % CI (1.50, 5.21) and poor medication adherence (AOR = 1.61, 95 % CI (1.02, 2.55) were significantly associated with depression. Being female (AOR = 3.13, 95 % CI (1.80, 5.44), being divorced (AOR = 2.51, 95 % CI (1.26, 5.00), having co morbid TB (AOR = 2.74, 95 % CI (1.37, 5.47) and perceived HIV stigma (AOR = 4.00, 95 % CI (2.40, 6.69) were also significantly associated with anxiety. CONCLUSION: Prevalence of depression and anxiety was high. Having perceived HIV stigma, HIV Stage III, poor social support and poor medication adherence were associated with depression. Whereas being female, being divorced and having co morbid TB and perceived HIV stigma were associated with anxiety. Ministry of health should give training on how to screen anxiety and depression among HIV patients and should develop guidelines to screen and treat depression and anxiety among HIV patients. BioMed Central 2016-11-02 /pmc/articles/PMC5094082/ /pubmed/27806711 http://dx.doi.org/10.1186/s12888-016-1037-9 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Tesfaw, Getachew Ayano, Getinet Awoke, Tadesse Assefa, Dawit Birhanu, Zelalem Miheretie, Getenet Abebe, Genet Prevalence and correlates of depression and anxiety among patients with HIV on-follow up at Alert Hospital, Addis Ababa, Ethiopia |
title | Prevalence and correlates of depression and anxiety among patients with HIV on-follow up at Alert Hospital, Addis Ababa, Ethiopia |
title_full | Prevalence and correlates of depression and anxiety among patients with HIV on-follow up at Alert Hospital, Addis Ababa, Ethiopia |
title_fullStr | Prevalence and correlates of depression and anxiety among patients with HIV on-follow up at Alert Hospital, Addis Ababa, Ethiopia |
title_full_unstemmed | Prevalence and correlates of depression and anxiety among patients with HIV on-follow up at Alert Hospital, Addis Ababa, Ethiopia |
title_short | Prevalence and correlates of depression and anxiety among patients with HIV on-follow up at Alert Hospital, Addis Ababa, Ethiopia |
title_sort | prevalence and correlates of depression and anxiety among patients with hiv on-follow up at alert hospital, addis ababa, ethiopia |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094082/ https://www.ncbi.nlm.nih.gov/pubmed/27806711 http://dx.doi.org/10.1186/s12888-016-1037-9 |
work_keys_str_mv | AT tesfawgetachew prevalenceandcorrelatesofdepressionandanxietyamongpatientswithhivonfollowupatalerthospitaladdisababaethiopia AT ayanogetinet prevalenceandcorrelatesofdepressionandanxietyamongpatientswithhivonfollowupatalerthospitaladdisababaethiopia AT awoketadesse prevalenceandcorrelatesofdepressionandanxietyamongpatientswithhivonfollowupatalerthospitaladdisababaethiopia AT assefadawit prevalenceandcorrelatesofdepressionandanxietyamongpatientswithhivonfollowupatalerthospitaladdisababaethiopia AT birhanuzelalem prevalenceandcorrelatesofdepressionandanxietyamongpatientswithhivonfollowupatalerthospitaladdisababaethiopia AT miheretiegetenet prevalenceandcorrelatesofdepressionandanxietyamongpatientswithhivonfollowupatalerthospitaladdisababaethiopia AT abebegenet prevalenceandcorrelatesofdepressionandanxietyamongpatientswithhivonfollowupatalerthospitaladdisababaethiopia |